- Home
- TARA vs DIBS Comparison
TARA vs DIBS Comparison
Compare TARA & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- DIBS
- Stock Information
- Founded
- TARA N/A
- DIBS 2000
- Country
- TARA United States
- DIBS United States
- Employees
- TARA N/A
- DIBS N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- DIBS Catalog/Specialty Distribution
- Sector
- TARA Health Care
- DIBS Consumer Discretionary
- Exchange
- TARA Nasdaq
- DIBS Nasdaq
- Market Cap
- TARA 136.3M
- DIBS 132.5M
- IPO Year
- TARA N/A
- DIBS 2021
- Fundamental
- Price
- TARA $4.26
- DIBS $3.04
- Analyst Decision
- TARA Strong Buy
- DIBS Hold
- Analyst Count
- TARA 4
- DIBS 1
- Target Price
- TARA $22.67
- DIBS N/A
- AVG Volume (30 Days)
- TARA 225.7K
- DIBS 106.5K
- Earning Date
- TARA 03-05-2025
- DIBS 05-07-2025
- Dividend Yield
- TARA N/A
- DIBS N/A
- EPS Growth
- TARA N/A
- DIBS N/A
- EPS
- TARA N/A
- DIBS N/A
- Revenue
- TARA N/A
- DIBS $88,257,000.00
- Revenue This Year
- TARA N/A
- DIBS $5.47
- Revenue Next Year
- TARA N/A
- DIBS $6.46
- P/E Ratio
- TARA N/A
- DIBS N/A
- Revenue Growth
- TARA N/A
- DIBS 4.22
- 52 Week Low
- TARA $1.60
- DIBS $2.82
- 52 Week High
- TARA $10.48
- DIBS $6.20
- Technical
- Relative Strength Index (RSI)
- TARA 48.51
- DIBS 37.06
- Support Level
- TARA $4.41
- DIBS $2.85
- Resistance Level
- TARA $4.63
- DIBS $3.14
- Average True Range (ATR)
- TARA 0.27
- DIBS 0.16
- MACD
- TARA 0.02
- DIBS 0.02
- Stochastic Oscillator
- TARA 34.75
- DIBS 53.66
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company's single reportable and operating segment contains two reporting units; 1stDibs, which consists of the company's online marketplace that enables commerce between sellers and buyers; and Design Manager, which is the company's separate online platform that is used to sell a software solution to interior designers. It generates revenue primarily from fees from seller marketplace services as well as other services, including advertisements and software services.